Pfeiffenberger Brent reported tax withholding involving 31,172 shares of Century Therapeutics, Inc. at $1.65 for −$51.4k on Nov 13, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
President and CEO
President and CEO
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$51,433.80Shares × reported price
Shares traded
31,172Common Stock
Price per share
$1.65Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
3,602,667Direct
Trade date
Nov 13, 2026Tax withholding
Filed
Nov 17, 2026, 4:47 PM ET4-day reporting delay
Accession
0002001162-26-000020Code F · Transaction 403843
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

IPSC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IPSC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +0.7%1w ago +23%1d ago +19%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.